Iteos Clinical Trials

Trials

Studies that name Iteos Clinical Trials as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:09 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT06547957 · A First-in-Human Study of EOS301984 as Monotherapy or Combination Therapy in Adult Participants With Advanced Solid Tumors

  iTeos Therapeutics · active not recruiting · Advanced Solid Tumors · study director
• Ph2
  NCT05403385 · Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer

  iTeos Therapeutics · active not recruiting · Metastatic NSCLC - Non-Small Cell Lung Cancer, Locally Advanced NSCLC - Non-Small Cell Lung Cancer · study director
• Ph1
  NCT05289492 · Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

  iTeos Therapeutics · terminated · Multiple Myeloma · study director
• Ph1
  NCT05117177 · New Formulation Study of Inupadenant (EOS100850) in Patients with Cancer

  iTeos Therapeutics · completed · Solid Tumor, Adult · study director
• Ph1/Ph2
  NCT05060432 · Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors

  iTeos Belgium SA · unknown · Advanced Cancer, Lung Cancer, Head and Neck Cancer · study director
• Ph1
  NCT03873883 · First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer

  iTeos Therapeutics · completed · Solid Tumor, Adult · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.